Clinical Trial Update: Pathogenesis of Glomerulosclerosis

View source ↗

Summary

Clinical trial update on the pathogenesis of glomerulosclerosis sponsored by NIDDK. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glomerular Disease
• Glomerulosclerosis

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Glomerular Disease | Status: COMPLETED